Marasmus
Overview
Plain-Language Overview
Marasmus is a severe form of malnutrition that primarily affects children and results from a significant deficiency in calories and protein. It impacts the whole body, especially the muscles and fat stores, leading to extreme weight loss and a very thin appearance. The condition weakens the immune system, making it harder for the body to fight infections. It also causes fatigue, delayed growth, and developmental problems. The main health concern is the body's inability to maintain normal functions due to lack of essential nutrients.
Clinical Definition
Marasmus is a form of severe protein-energy malnutrition characterized by a marked deficiency in caloric intake leading to depletion of both fat stores and muscle mass. It typically results from prolonged inadequate intake of all macronutrients, especially in infants and young children. The core pathology involves catabolism of body tissues to meet energy demands, causing severe wasting without edema. Clinically, it presents with severe weight loss, muscle atrophy, and loss of subcutaneous fat, with preserved serum albumin levels distinguishing it from kwashiorkor. It is a major cause of morbidity and mortality in resource-limited settings due to increased susceptibility to infections and impaired immune function.
Inciting Event
Prolonged inadequate caloric intake due to famine, neglect, or poverty
Chronic gastrointestinal infections causing malabsorption and nutrient loss
Increased metabolic demands from chronic illness or infection without compensatory nutrition
Sudden loss of food supply or caregiver leading to starvation
Latency Period
Weeks to months of sustained caloric deficiency before clinical signs develop
Gradual progression of weight loss and muscle wasting over time
Delayed symptom onset due to initial fat store utilization before muscle catabolism
Diagnostic Delay
Misattribution of symptoms to chronic infections or other diseases
Lack of awareness of malnutrition signs in early stages by healthcare providers
Overlap with kwashiorkor leading to diagnostic confusion
Limited access to healthcare delaying nutritional assessment and diagnosis
Clinical Presentation
Signs & Symptoms
Chronic energy deficiency leading to extreme weight loss
Irritability and lethargy due to malnutrition
Delayed growth and development in children
Cold intolerance from loss of insulating fat
Increased susceptibility to infections due to immune suppression
History of Present Illness
Progressive weight loss with marked muscle wasting and loss of subcutaneous fat
Decreased appetite and lethargy developing over weeks to months
Recurrent infections due to immunosuppression
Delayed developmental milestones and poor growth in children
Dry, thin skin and sparse hair often reported by caregivers
Past Medical History
Previous episodes of malnutrition or failure to thrive
Chronic illnesses such as HIV, tuberculosis, or parasitic infections
History of gastrointestinal disorders causing malabsorption
Recent or recurrent infections increasing metabolic demands
Family History
No direct genetic inheritance but familial poverty and food insecurity increase risk
Family history of malnutrition in siblings or close relatives in resource-poor settings
Rare familial syndromes causing malabsorption may contribute in some cases
[]
Physical Exam Findings
Severe muscle wasting with loss of subcutaneous fat leading to a 'skin and bones' appearance
Prominent ribs and clavicles due to loss of fat and muscle mass
Dry, thin, and wrinkled skin with decreased skin turgor
Visible veins due to loss of subcutaneous tissue
Enlarged liver may be present due to fatty infiltration
Diagnostic Workup
Diagnostic Criteria
Diagnosis is based on clinical assessment showing severe wasting with weight-for-height below -3 standard deviations on WHO growth charts. Key findings include visible loss of subcutaneous fat, muscle wasting, and absence of edema. Laboratory tests typically show normal or low serum albumin, differentiating it from kwashiorkor. Diagnosis is confirmed by history of prolonged inadequate nutritional intake and exclusion of other causes of wasting.
Pathophysiology
Key Mechanisms
Severe caloric deficiency leading to global energy depletion and catabolism of muscle and fat stores
Protein-energy malnutrition causing loss of somatic and visceral protein mass
Impaired immune function due to decreased synthesis of immunoglobulins and immune cells
Reduced basal metabolic rate as an adaptive response to conserve energy
Electrolyte imbalances including hypokalemia and hypophosphatemia contributing to clinical deterioration
| Involvement | Details |
|---|---|
| Organs | Liver function is impaired due to decreased protein synthesis and fat metabolism abnormalities |
Heart muscle mass is reduced, increasing risk of cardiac complications | |
Kidneys may be affected by electrolyte imbalances and dehydration associated with malnutrition | |
| Tissues | Muscle tissue undergoes significant atrophy due to protein-energy deficiency |
Adipose tissue is markedly reduced, reflecting depletion of fat stores | |
Gastrointestinal mucosa may be atrophic, impairing nutrient absorption and barrier function | |
| Cells | Adipocytes are depleted in marasmus, reflecting loss of fat stores and energy reserves |
Skeletal muscle cells undergo atrophy due to severe protein deficiency causing muscle wasting | |
Immune cells such as lymphocytes are reduced, leading to immunodeficiency and increased infection risk | |
| Chemical Mediators | Cortisol levels are elevated in marasmus, promoting catabolism and muscle breakdown |
Insulin-like growth factor 1 (IGF-1) is decreased, impairing growth and tissue repair | |
Proinflammatory cytokines like TNF-alpha may be elevated, contributing to metabolic disturbances |
Treatments
Pharmacological Treatments
Multivitamin and mineral supplementation
- Mechanism:
Replenishes essential micronutrients depleted in marasmus to support metabolic and immune functions
- Side effects:
Allergic reactions
Gastrointestinal upset
- Clinical role:
Supportive
Antibiotics
- Mechanism:
Treats or prevents secondary bacterial infections common in severe malnutrition
- Side effects:
Antibiotic resistance
Gastrointestinal disturbances
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Gradual nutritional rehabilitation with carefully monitored refeeding to avoid refeeding syndrome and restore body weight and muscle mass
Management of underlying causes such as chronic illness or socioeconomic factors contributing to protein-energy malnutrition
Provision of psychosocial support and education to caregivers to ensure sustained nutritional improvement
Prevention
Pharmacological Prevention
Vitamin A supplementation to reduce morbidity and mortality
Zinc supplementation to improve immune function and reduce diarrhea duration
Iron supplementation cautiously used to treat anemia after infection control
Antibiotic prophylaxis in severely malnourished children with infections
Non-pharmacological Prevention
Early nutritional rehabilitation with adequate caloric and protein intake
Breastfeeding promotion to provide optimal infant nutrition
Improved sanitation and hygiene to reduce infection risk
Community education on balanced diet and food security
Outcome & Complications
Complications
Cardiac arrhythmias from electrolyte disturbances
Hypothermia due to loss of insulating fat and impaired thermoregulation
Severe infections including sepsis due to immune compromise
Multi-organ failure in advanced cases
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Marasmus versus Kwashiorkor
Marasmus | Kwashiorkor |
|---|---|
Severe muscle wasting and loss of subcutaneous fat without edema | Presence of edema, hepatomegaly, and skin changes such as hyperpigmentation and desquamation |
Normal or mildly decreased albumin without edema | Marked hypoalbuminemia leading to edema |
Overall calorie deficiency including protein and energy | Primarily protein deficiency with relatively preserved calorie intake |
Marasmus versus Chronic illness-related malnutrition
Marasmus | Chronic illness-related malnutrition |
|---|---|
Malnutrition due to primary inadequate intake without underlying chronic disease | Malnutrition develops in the context of a chronic disease such as cancer or chronic infection |
Normal or low inflammatory markers | Elevated acute phase reactants (e.g., CRP, ESR) due to chronic inflammation |
Rapid improvement with nutritional repletion | Poor or slow improvement despite adequate nutritional rehabilitation |
Marasmus versus Anorexia nervosa
Marasmus | Anorexia nervosa |
|---|---|
Commonly affects infants and young children in resource-poor settings | Typically affects adolescents and young adult females |
No psychiatric disturbance; malnutrition due to inadequate intake from external causes | Presence of body image distortion and intentional food restriction |
Severe wasting without lanugo or bradycardia | Severe weight loss with lanugo hair and bradycardia |
Marasmus versus Celiac disease
Marasmus | Celiac disease |
|---|---|
Malnutrition due to inadequate calorie and protein intake without autoimmune enteropathy | Autoimmune reaction to gluten causing intestinal villous atrophy |
May have diarrhea but primarily wasting without malabsorption syndrome | Chronic diarrhea, steatorrhea, and abdominal distension |
No specific serologic markers or biopsy findings | Positive anti-tissue transglutaminase antibodies and villous atrophy on biopsy |
Marasmus versus Congenital heart disease with failure to thrive
Marasmus | Congenital heart disease with failure to thrive |
|---|---|
No cardiac signs; malnutrition due to nutritional deficiency | Signs of cardiac dysfunction such as tachypnea, hepatomegaly, and cyanosis |
Malnutrition develops progressively due to inadequate intake | Symptoms often present early in infancy with feeding difficulties |
Normal cardiac imaging | Abnormal echocardiogram showing structural heart defects |